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Random minitransposon mutagenesis was used to identify genes involved in the survival of Bordetella bron-
chiseptica within eukaryotic cells. One of the mutants which exhibited a reduced ability to survive intracellular-
ly harbored a minitransposon insertion in a locus (ris) which displays a high degree of homology to two-component
regulatory systems. This system exhibited less than 25% amino acid sequence homology to the only other two-
component regulatory system described in Bordetella spp., the bvg locus. A risA*-*lacZ translational fusion was
constructed and integrated into the chromosome of B. bronchiseptica. Determination of b-galactosidase activity
under different environmental conditions suggested that ris is regulated independently of bvg and is optimally
expressed at 37°C, in the absence of Mg21, and when bacteria are in the intracellular niche. This novel reg-
ulatory locus, present in all Bordetella spp., is required for the expression of acid phosphatase by B. bronchi-
septica. Although catalase and superoxide dismutase production were unaffected, the ris mutant was more sen-
sitive to oxidative stress than the wild-type strain. Complementation of bvg-positive and bvg-negative ris mutants
with the intact ris operon incorporated as a single copy into the chromosome resulted in the reestablishment
of the ability of the bacterium to produce acid phosphatase and to resist oxidative stress. Mouse colonization
studies demonstrated that the ris mutant is cleared by the host much earlier than the wild-type strain, sug-
gesting that ris-regulated products play a significant role in natural infections. The identification of a second
two-component system in B. bronchiseptica highlights the complexity of the regulatory network needed for or-
ganisms with a life cycle requiring adaptation to both the external environment and a mammalian host.
Bordetella bronchiseptica is a respiratory pathogen that
causes diseases in many warm-blooded animals (28). B. bron-
chiseptica and other Bordetella spp. produce several virulence
factors which have been implicated in bacterial attachment and
colonization, such as filamentous hemagglutinin, pertactin, and
fimbriae, and others, such as the dermonecrotic toxin and the
adenylate cyclase hemolysin (32, 37, 42, 43), which seem to be
responsible for tissue damage (35, 57), suppression of antibody
responses (39), and alteration of host clearance mechanisms
(25). The expression of most of the virulence genes is coordi-
nately regulated at the transcriptional level by the bvg (for
Bordetella virulence gene) locus in response to environmental
signals, such as changes in temperature and the presence of
nicotinic acid or MgSO4 (52, 72). This locus encodes two pro-
teins, BvgS and BvgA, which are the environmental sensor and
transcriptional activator, respectively, of a two-component reg-
ulatory system.
In recent years, several reports have demonstrated the ca-
pacity of different Bordetella spp. to invade and survive within
epithelial cells (22, 23, 61, 63), dendritic cells (33, 34), and
macrophages and polymorphonuclear leukocytes (9, 25, 60,
66). Persistence in a cellular reservoir might allow bacteria to
escape from host clearance mechanisms and might also favor a
chronic course of infection (7, 30, 57, 69); the bacteria would
also be located in an environment rich in nutrients and devoid
of competing microorganisms (24).
The processes employed by eukaryotic cells to kill intracel-
lular microorganisms have been extensively characterized (40).
However, bacterial genes involved in resistance to intracellular
killing and the regulation of such genes are less well charac-
terized (11). In contrast to other Bordetella spp., in which
intracellular survival seems to be dependent on bvg-activated
products (7, 22, 25, 60), both wild-type and bvg-negative
B. bronchiseptica strains are able to invade and survive within
eukaryotic cells (33, 34, 61, 63). In addition, recent studies have
suggested that, at least in macrophages, bvg-negative mutants
may have a selective advantage for long-term survival (7). This
suggests that the synthesis of a product(s) involved in intracel-
lular survival might be independent of, or repressed by, the bvg
locus.
To identify genes encoding proteins involved in the intracel-
lular survival process, bacterial mutants impaired in survival
were generated by random minitransposon mutagenesis. This
approach led to the identification of a novel two-component
regulatory system which is present in all Bordetella spp. and is
required for bacterial resistance to oxidative stress, production
of acid phosphatase, and in vivo persistence in mice.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. B. bronchiseptica BB7866 (a sponta-
neous DbvgS avirulent-phase derivative of BB7865 [31]), Bordetella pertussis
Tohama I (73) and BP338 (72), Bordetella avium 35086 (Culture Collection of
the University of Go¨teborg, Go¨teborg, Sweden), and Bordetella parapertussis
15311 and MS/180 (71) were used throughout this work. Bordetellae were grown
at 25, 30, or 37°C on Bordet-Gengou (BG) agar base (Difco Laboratories,
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Detroit, Mich.) supplemented with 1% glycerol and 10% (vol/vol) defibrinated
horse blood and in SS-X broth (65). SS-X broth containing 20 mM MgSO4
instead of NaCl (SS-C) was used to downregulate bvg-activated products.
Escherichia coli SM10(lpir) (50) was used as a donor strain for the conjugative
transfer of pUT::mini-Tn5Km2 (18) and pBSL204::miniTn5Tc (4), whereas
E. coli XL1-Blue (Stratagene) was used as the recipient strain for cloning ex-
periments utilizing the vector pUC18Not (36). E. coli Q358(pR751::Tn813) (64)
was used for the in vivo transfer of the Kmr cassette into the spontaneous
nalidixic acid- and rifampicin-resistant virulent strain BB7865. E. coli strains
were grown in or on Luria-Bertani broth or agar (58).
Generation of mutants impaired in intracellular survival ability. Random
minitransposon mutagenesis of B. bronchiseptica with mini-Tn5Km2 was per-
formed as described by Herrero et al. (36). In brief, the donor strain, E. coli
SM10(lpir) containing pUT::mini-Tn5Km2, and the recipient strain, BB7866,
were mixed in a 1:1 ratio in 0.7% saline and incubated overnight on BG agar.
Colonies were collected and suspended in 0.7% saline, and appropriate dilutions
were plated onto SS-X agar supplemented with kanamycin at 50 mg/ml (allowing
selection for the minitransposon) and cephalexin at 50 mg/ml (allowing negative
selection for the donor E. coli). The presence of insertion mutants resulting from
cointegration events was excluded by their sensitivity to ampicillin (the marker of
the suicide vector).
In vivo transfer of the Kmr cassette into the bvg-positive strain BB7865 and
complementation studies. The Kmr cassette, inserted into the avirulent strain
BB7866 ris, was transferred into the virulent strain BB7865 (Nalr Rifr) by the in
vivo transfer technique described by Smith and Walker (64). Briefly, E. coli
Q358(pR751::Tn813), which contains the conjugative plasmid pR751, harboring
the cointegrate-forming transposon Tn813, was conjugally mated with BB7866
ris, inducing the transfer of the plasmid into BB7866 ris. The transposase en-
coded by Tn813 catalyzes the permanent cointegration of the plasmid into the
chromosome. This strain (resistant to trimethoprim at 50 mg/ml and to kanamy-
cin at 50 mg/ml) was then mated with BB7865 (Nalr Rifr). The chromosomally
integrated tra genes of pR751 promote chromosome transfer. The Kmr cassette
was thus transferred to the recipient strain, and transconjugants were selected by
their resistance to rifampin at 100 mg/ml and to kanamycin at 50 mg/ml. Correct
integration was confirmed by Southern blot analysis (data not shown). Kmr
cassette insertion into BB7865 ris and BB7866 ris was complemented by chro-
mosomal insertion of the ris locus via pBSL204::miniTn5Tc containing the 4.1-kb
NotI fragment of pHJ2, thereby generating BB7865 ris::Tn5Tc-ris1 and BB7866
ris::Tn5Tc-ris1.
Tissue culture methods and invasion assays. B. bronchiseptica insertion mu-
tants were tested for their ability to survive in the spleen dendritic cell line CB1
(54) and the macrophage-like cell line J774A.1 (ATCC TIB 67). Dendritic cells
were maintained in Iscove’s modified Dulbecco’s medium (Sigma Chemie
GmbH, Deisenhofen, Germany) supplemented with 5% fetal calf serum and 5
mM glutamine (GIBCO Laboratories, Eggenstein, Germany), and cell line
J774A.1 was maintained in Dulbecco’s modified Eagle medium supplemented
with 4.5 g of glucose (Sigma) per liter, 10% fetal calf serum, 5 mM glutamine,
and 1.5 g of NaHCO3 per liter, both in an atmosphere containing 5% CO2 at
37°C. Cells were seeded at a concentration of approximately 5 3 104 per well in
24-well tissue culture plates (Inter Med NUNC, Roskilde, Denmark) and in-
fected for 2 h (CB1 cells) or 30 min (J774A.1 cells), and invasion assays were then
performed as previously described (33, 34).
DNA manipulations. Standard methods were used for plasmid purification,
agarose gel electrophoresis, ligation, transformation, and restriction analysis
(58). Restriction endonucleases and T4 DNA ligase were purchased from New
England Biolabs (Schwalbach, Germany). DNA purification from agarose gels
was performed with a Jet Sorb Gel Extraction Kit (Genomed, Bad Oehnhausen,
Germany). Oligonucleotides were synthesized by using an Applied Biosystems
394-8 DNA synthesizer. Colony blotting was carried out by transferring bacteria
from agar plates to Biodyne A nylon membranes (Pall, Dreieich, Germany),
which were processed according to the procedure of Sambrook et al. (58). PCR
amplification of the risA and the risS genes from total DNA of different Borde-
tella spp. was performed with DNA polymerase MobiTaqK (MoBiTec, Go¨ttin-
gen, Germany) in accordance with the manufacturer’s instructions, using the
primer pairs 59-GTGAACACCCACTAGCCGCTGGCTT-39-59-CAAGGTTTC
TGAACAGTCTGCGCATG-39 and 59-TGGCGGCAGTTGACCTAATG-39-
59-TCAAGCCCTAAATTCTACGCT-39, respectively.
Cloning of the two-component system and DNA sequence analysis. To clone
the minitransposon and flanking DNA sequences, chromosomal DNA was di-
gested with a restriction endonuclease for which there existed a cleavage site
flanking the gene coding for kanamycin resistance (either NotI or EcoRI) and
ligated with pUC18Not. After transformation of the ligation mixture into E. coli
XL1-Blue, transformants which were resistant to ampicillin (pUC18Not marker)
and kanamycin (mini-Tn5 marker) were selected. To clone the full operon, a
gene library was generated by cloning NotI-digested chromosomal DNA from
BB7866 into pUC18Not. The resulting recombinant clones of E. coli XL1-Blue
were screened, using the 1.2-kb digoxigenin (DIG)-labelled NotI-EcoRI frag-
ment of pHJ1 (see Results) as a probe. A positive clone, containing a hybrid
plasmid (pHJ2) with the 4.1-kb NotI fragment spanning the insertion site, was
identified. Sequencing was performed by the method of Sanger et al. (59), using
a Taq Dyedeoxy Terminator Cycle Sequencing Kit (ABI Prism; Applied Biosys-
tems) and an automated sequencer (model 373; Applied Biosystems). Homology
searches were conducted with the FASTA program (55).
Construction of a risA*-*lacZ fusion. For the construction of a risA9-9lacZ
fusion, a PCR-amplified (using the primers 59-CGGAATTCACGCGCACCCA
GCCAG-39 and 59-GCGCAGCCCGGGATCATCGTCGAC-39) EcoRI-SmaI
fragment containing 732 bp of the upstream sequence of risA and 76 bp of the
risA gene was cloned into pUJ9 (18). Then, the transcriptional terminators of the
rrnB gene, T1 and T2, present in pKK232-8 (10) were amplified by PCR as a
313-bp fragment and inserted upstream of the fusion to prevent transcriptional
read-through from promoters located upstream of the integration site. The
cassette encompassing the transcriptional terminators and the fusion was cloned
as a NotI fragment into pUT::mini-Tn5Km2. The minitransposon was then in-
serted into the chromosomes of BB7865 and BB7866, thereby generating
BB7865 risA9-9lacZ and BB7866 risA9-9lacZ, respectively. Three recombinant
strains harboring the insertion in different chromosomal sites which did not affect
the growth characteristics of the bacterium were selected for further analysis.
b-Galactosidase activity was generally quantified by the method of Miller (48).
To achieve a higher detection sensitivity, enabling the determination of the b-
galactosidase produced by intracellular bacteria, the b-Gal Reporter Gene Assay
Kit (Boehringer, Mannheim, Germany) was used according to the manufactur-
er’s instructions. In brief, cells were infected as described above, and 2 or 24 h
after gentamycin treatment, the monolayers were lysed with H2O and the bac-
teria were harvested by centrifugation. One aliquot was taken to determine the
number of bacteria (CFU), and the rest of the cells were lysed and the amount
of b-galactosidase present in the sample (in femtograms per CFU) was deter-
mined. The enzymatic activities produced by bacteria grown in tissue culture
medium and in SS-X medium were measured as controls.
Southern blot analysis. Chromosomal DNA was isolated by using a genomic
DNA purification kit (Qiagen, Hilden, Germany), digested with either EcoRI or
NotI, separated on 0.7% agarose gels, and transferred to Pall Biodyne B nylon
membranes (58). The DNA was probed with DIG-labelled oligonucleotides
(DIG Oligonucleotide 39-End Labelling Kit; Boehringer) that were complemen-
tary to the O end (59-GCCGCACTTGTGTATAAGAGTC-39) and the I end
(59-GGCCAGATCTGATCAAGCGACA-39) of the minitransposon (18). After
hybridization was performed by using a DIG Luminescent Detection Kit for
Nucleic Acids (Boehringer), the light emissions of bound probes were recorded
on Kodak X-ray film.
Northern blot and RACE analysis. Total RNA was isolated by using a total
RNA isolation kit from Qiagen. RNA (15 mg) was subjected to electrophoresis
in a denaturing agarose-formaldehyde gel and transferred to Pall Biodyne B
nylon membranes (58). A 630-bp BspEI-SalI risA internal DNA fragment was
used as a probe. Hybridization was performed at 42°C in a solution containing
50% formamide, 13 Denhardt’s solution, 1% sodium dodecyl sulfate (SDS), 83
SSC (13 SSC is 150 mM sodium chloride and 15 mM sodium citrate), 10%
dextran sulfate, and 100 mg of salmon sperm DNA per ml. The blot was washed
twice in 23 SSC–0.1% SDS for 15 min at 50°C and twice in 0.13 SSC–0.1% SDS
for 15 min at room temperature and then autoradiographed for 24 h.
For determination of the transcriptional start site, the RNA was analyzed with
a 59-39 rapid amplification of cDNA ends (RACE) system (Boehringer). Briefly,
after reverse transcription with the primer 59-GGCCTTGGCGGTCAGCATG
ATGAT-39, which hybridizes to positions 249 to 273 of the risA gene, the cDNA
was 39 dA tailed and PCR amplified with an oligo(dT) primer and a nested
primer (59-AGGAGATCGCGCAGTCGGGGATCAT-39) complementary to
positions 50 to 74 of the risA gene. The resulting product was subsequently
cloned and sequenced.
Urease, motility, acid phosphatase, and SOD determinations. Urease and
motility were determined as previously described (46, 74). For acid phosphatase
determinations, bacteria were harvested in the late exponential phase, cell pellets
were disrupted by using a French press, the lysates were centrifuged at 3,000 3
g for 10 min, and the supernatants were tested for phosphatase activity by a
modification of the method of Dassa et al. (17). For superoxide dismutase (SOD)
determinations, bacterial cells were disrupted by using a French press and the
lysates, each containing 100 to 200 mg of protein, were loaded onto a 10%
nondenaturing polyacrylamide gel, electrophoresed at 80 V, and assayed for
SOD activity as described by DeShazer et al. (19).
Sensitivity to oxidative stress. Susceptibility to paraquat (methyl viologen;
Sigma) was determined by a disk diffusion test (11). Overnight cultures of strains
BB7865 and BB7866, the ris mutants, and the corresponding ris complementa-
tion strains were diluted in saline, and 106 cells of each were plated onto SS-X
and SS-C agar. A filter (0.22-mm pore size) soaked in 10 mM paraquat in sterile
water was centered onto each plate, and the bacteria were incubated 48 h. The
zone of growth inhibition on each plate was determined in two axes relative to
the disk, and the averages were calculated. To determine bacterial sensitivity to
H2O2, bacterial suspensions were adjusted to an A600 of 0.1 in SS-X broth, H2O2
was added to a final concentration of 1 or 5 mM, and samples were further
incubated at 37°C. Aliquots were taken after 0, 15, and 30 min, diluted, and
plated to determine the number of viable bacteria (CFU) with respect to the
inoculum.
Two-dimensional gel electrophoresis. French press lysates were separated by
isoelectrofocusing on a pH gradient ranging from 3 to 10 in capillary gels, using
a Mini-Protean II 2-D cell (Bio-Rad, Munich, Germany). After separation of
proteins according to their isoelectric points in the first dimension, they were
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further separated in a second dimension by sodium dodecyl sulfate-polyacrylam-
ide gel electrophoresis (41), and protein spots were visualized by silver staining
(Bio-Rad).
In vivo colonization studies. Approximately 106 bacteria were resuspended in
1% Casamino Acids in phosphate-buffered saline and administered intranasally
to 4-week-old female BALB/c mice. Groups of animals were sacrificed at 2 h and
at 4, 8, 14, and 21 days after challenge (four mice per time point). Their lungs were
homogenized by using a Polytron PT 1200 homogenizer (Kinematica, Lucerne,
Switzerland), and the numbers of viable microorganisms were determined by
plating appropriate dilutions onto BG agar supplemented with cephalexin (50
mg/ml).
Statistical analysis. The statistical significance of the results has been evalu-
ated by the Students t test, using Statgraphic Plus for Windows version 2.0
software (Statistical Graphic Corp.); differences were considered significant at
P # 0.05.
Nucleotide sequence accession number. The sequence data for the ris locus of
B. bronchiseptica BB7866 have been submitted to the EMBL database and
appear under accession no. Z97065.
RESULTS
Identification of a second two-component regulatory system in
B. bronchiseptica. Survival of B. bronchiseptica within eukaryo-
tic cells is bvg independent (33, 34, 61, 63). Therefore, to facil-
itate the identification of B. bronchiseptica genes which are in-
volved in intracellular survival, a bvg-negative background was
chosen for mutagenesis studies. BB7866, the bvgS deletion de-
rivative of the wild-type strain BB7865, was randomly muta-
genized by using a minitransposon. Approximately 1,000 Kmr
transconjugants with stable integration of the minitransposon
were generated. The insertion mutants that were able to con-
serve the growth properties of the parental strain in liquid
medium were screened for their ability to survive within CB1
cells. A BB7866 derivative that exhibited a moderate (32%)
but statistically significant (P # 0.05) reduction in intracellular
survival capacity after 24 h of infection was selected. This clone
was further characterized by Southern blot analysis.
The cassette present in the minitransposon coding for resis-
tance to kanamycin is flanked by the sequences recognized by
the endonucleases EcoRI and NotI. Therefore, total DNA was
digested with either EcoRI or NotI, separated in agarose gels,
and analyzed by Southern blotting with DIG-labelled oligonu-
cleotides specific to the mini-Tn5 I and O ends, respectively
(data not shown). The size of the EcoRI and NotI fragments
containing the Kmr cassette and the flanking Bordetella chro-
mosomal region established that mini-Tn5Km2 was inserted
within a 4.1-kb NotI fragment (Fig. 1A). Then, a 3.0-kb NotI
fragment containing the Kmr cassette together with flanking
chromosomal DNA (1.2 kb) was cloned into the NotI site of
pUC18Not, thereby generating pHJ1. DNA sequence analysis
revealed that the minitransposon was integrated into an open
reading frame (ORF) encoding a product that exhibits a high
degree of homology to the NH2-terminal regions of response
regulators from bacterial two-component regulatory systems
(Fig. 1B). This gene, which is distinct from bvg, was designated
risA (for regulator of intracellular stress response).
Most of the two-component systems are encoded by an
operon in which the response regulator is found upstream and
the second component, the sensor kinase, is located down-
stream. To clone the full operon, a gene library was generated
by cloning NotI-digested chromosomal DNA from BB7866 into
pUC18Not. The resulting recombinant clones were screened with
the 1.2-kb NotI-EcoRI fragment of pHJ1 as a probe. A positive
clone which contained a hybrid plasmid (pHJ2) with the 4.1-kb
NotI fragment spanning the insertion site was identified. The
pHJ2 insert contains both risA and, 4 bp downstream, a second
ORF, designated risS, encoding a product with homology to
sensor kinases (Fig. 1B).
Northern blot analysis confirmed that risA and risS are co-
transcribed in a bicistronic mRNA of 2.42 kb (data not shown).
In addition, the small distance between the two genes suggests
that the expression of the corresponding proteins is coupled at
the translational level. The analysis by RACE allowed the
estimation of the position of the transcriptional start site at
nucleotide 243. No typical rho-independent transcription ter-
mination site (70) was observed downstream of risS.
To assess the role of the ris locus in a bvg-positive back-
ground, the mutation present in BB7866 ris was transferred
into BB7865 by an in vivo transfer technique (64). Both
BB7865 ris and BB7866 ris exhibited moderate (41 and 32%,
respectively) but statistically significant (P # 0.05) reductions
in intracellular survival capacities, compared to those of the
parental control strains, after 24 h of infection (Fig. 2A and B).
Since professional phagocytes constitute the first line of de-
fense against microbial pathogens, the capacities of BB7865
and its ris derivative to survive in the macrophage-like cell line
J774A.1 were investigated. A clear reduction in the intracellu-
lar survival of the mutant strain was also observed in this cel-
lular system (Fig. 2C) after 4 and 24 h of infection (45 and
59%, respectively). To further confirm the role of products
encoded by the ris locus in the observed phenotype, the ris
mutant strains were complemented under physiologic mono-
copy conditions by transferring the 4.1-kb NotI fragment of
pHJ2 into the chromosome via a second minitransposon. The
presence of the ris locus reestablished the intracellular survival
capacities of the ris mutants (Fig. 2).
Sequence homology of the ris products and other two-com-
ponent regulatory systems. The risA (0.735-kb) and risS (1.425-
kb) genes encode proteins with estimated molecular masses of
27.7 and 52.6 kDa and predicted isoelectric points of 6.46 and
7.14, respectively. The GC contents of risA (61.4%) and risS
(67.4%) are similar to the overall GC content of the B. bron-
chiseptica chromosome (64%), which argues against the recent
acquisition of the ris genes by B. bronchiseptica. The risA and
risS ORFs, as well as their products, were analyzed for homol-
ogy to other genes and their products by using the FASTA
program (55) with a gap extension penalty of 4. RisA and RisS
exhibited the highest degree of homology to E. coli OmpR and
EnvZ, with 66.5% (236-amino-acid overlap) and 29.5% (437-
amino-acid overlap) identity at the protein level, respective-
ly (Fig. 3). RisA showed the highest degree of homology to
OmpR in the NH2-terminal region of the protein, which is
conserved among response regulators and contains the phos-
phorylation site (Asp at position 60) as well as the aspartate
residues necessary for the generation of an acidic pocket (Asp
at positions 17 and 18) and the conserved lysine at position 110
(53). RisS showed the highest degree of homology to the con-
served COOH-terminal region of EnvZ and exhibited homol-
ogy to other sensor kinases in the three functional regions,
whereas the overall degree of similarity was relatively low (38,
53, 67). The predicted autophosphorylation site was present in
region I (His at position 258), and the AsnXXXAsnAla motif,
which appears to be required for phosphotransfer and is com-
mon to all members of the EnvZ family (51), was present in
region II (positions 360 to 365). Finally, in region III, two
conserved glycine-rich sequences (GXG and GXGXG) (53)
and a conserved phenylalanine at position 412 (39) were ob-
served. The identity between EnvZ and RisS in the predicted
periplasmic domains was only 15% (126-amino-acid overlap),
in contrast to an overall identity of 29.5%, suggesting that
different environmental signals might be sensed by the peri-
plasmic domains of EnvZ and RisS. The levels of homology
between RisA-RisS and the components of the only other
known Bordetella response regulator system, BvgA-BvgS, are
23% (RisA versus BvgA) and 25% (RisS versus BvgS), respec-
tively. It has been described that the overlap between the
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termination and initiation codons observed in ompR-envZ fa-
vors translational coupling, thereby allowing an optimal molar
ratio between the two proteins (14, 44). This supports the
hypothesis that the ATG located 4 bp downstream of the risA
stop codon is the start codon of risS.
Regulation of ris expression. To investigate which environ-
mental signals are involved in the activation of ris, a trans-
lational fusion between risA and the lacZ reporter gene
was generated. The resulting construct was integrated into
the chromosomes of BB7865 and BB7866 in a single copy.
FIG. 1. (A) Linear restriction map of the ris locus present in B. bronchiseptica BB7866. The insertion site of mini-Tn5Km2 in risA is indicated. (B) Nucleotide
sequence and predicted translation products of the ris locus. The transcriptional start site identified by RACE analysis (11), the putative promoter consensus sequences
(underlined), the position of the transposon insertion (arrowhead), and the stop codons are indicated.
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Due to the high degree of similarity between ris and other
osmosensory two-component systems (e.g., ompR-envZ), we
first determined whether increments in osmolarity resulted in
modification of the amounts of b-galactosidase expressed by
the recombinant strains. Supplementation of SS-X broth with
NaCl in concentrations ranging between 20 and 300 mM did
not result in a significant change in expression of the reporter
gene in either BB7865 risA9-9lacZ or BB7866 risA9-9lacZ (Fig.
4A). This and the lack of alteration in the outer membrane
profile between the parental strains and their ris mutants (data
not shown) suggest that the ris locus is not a homolog of the
ompR-envZ locus in B. bronchiseptica.
To assess the influence of bvg on ris expression, BB7865
risA9-9lacZ was grown under bvg-modulating conditions, such
as in SS-X medium at 25°C or in the presence of either 5 mM
nicotinic acid or 20 mM MgSO4 at 37°C. Expression of b-ga-
lactosidase in BB7865 risA9-9lacZ was reduced 42% after growth
at 25°C and 31% in the presence of MgSO4. However, the
enzymatic activity was not reduced in BB7865 ris9-9lacZ grown
in the presence of nicotinic acid or in the bvgS avirulent strain
BB7866 ris9-9lacZ. This indicates that bvg has no influence on
ris expression and that the observed effect may be attributed to
a downregulation at low temperatures. A similar downregula-
tion of risA was observed when bacteria were grown in the
FIG. 2. B. bronchiseptica ris mutants exhibit reduced intracellular survival capacities. CB1 (A and B) and J774A.1 (C) cells were infected with B. bronchiseptica
strains and their corresponding ris derivatives, and the numbers of viable intracellular bacteria were determined at different time intervals. The complementation of
ris-deficient strains with the intact ris locus in monocopy reestablished the phenotype to wild-type levels. The results are averages of three independent determinations;
standard errors of the means are indicated by vertical lines. Differences between wild-type and recombinant strains were significant at P # 0.05 (M).
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presence of 20 mM MgCl2 instead of MgSO4. This suggests
that Mg21 has an effect on ris expression. It is likely that the
intraphagosomal Mg21 concentration is low enough to en-
hance ris expression, as occurs in Mg21-repressed intracellu-
larly activated genes of Salmonella spp. (26, 27). b-Galactosi-
dase activity was not affected when bacteria were grown at
pH 5.8. Although phagosome acidification has been shown
to stimulate gene expression in many intracellular patho-
gens, the environmental parameters of B. bronchiseptica-con-
taining phagosomes have not yet been elucidated. To establish
the influence of the eukaryotic cell environment on ris expres-
sion, the level of b-galactosidase produced during bacterial
infection of CB1 cells was determined. The expression of the
reporter gene was increased by 48- and 24-fold after 4 and 24 h
of infection, respectively (Fig. 4B). This clearly demonstrates
that the ris locus is activated upon bacterial infection of eu-
karyotic cells.
Identification of the ris locus in other Bordetella spp. To
assess whether the ris regulatory system is conserved among
different Bordetella spp., DNA from B. avium, B. parapertussis,
B. pertussis, and B. bronchiseptica was digested with EcoRI and
analyzed by Southern blotting with a probe encompassing a
500-bp internal fragment of risA. A band of approximately 8.6
kb that specifically reacted with the probe was observed in all
species (data not shown). The DNA was also used as a tem-
plate in a PCR with primers based on the 59 and 39 ends of risA
and risS. A 735-bp and a 1,425-bp fragment, respectively, were
amplified in all tested strains; sequence analysis of the PCR
products revealed 100% identity between B. bronchiseptica
(strain BB7866), B. avium (strain 35086), and B. parapertussis
(strains MS/180 and 15311) risA fragments and a single con-
servative exchange (C to A) in B. pertussis (strains BP338 and
Tohama I) at position 546 of risA. When the risS gene was
analyzed, 100% identity between B. bronchiseptica (strain
BB7866) and B. parapertussis MS/180 was found, whereas one
exchange was observed in B. parapertussis 15311 and B. pertus-
sis (strains BP338 and Tohama I), at position 1,414 (C to G),
and two exchanges were evident in B. avium 35086, at positions
FIG. 3. Comparison of RisA-RisS to other two-component regulatory systems. (A) RisA of B. bronchiseptica (Bbron) showed homology to the response regulators
OmpR of E. coli (Ecoli) and S. typhimurium (Salty), CpxR of E. coli, PhoP of Bacillus subtilis (Bacsu), PetR of Rhodobacter capsulatus (Rhoca), PhoB of Shigella
dysenteriae (Shidy), VirG of Agrobacterium tumefaciens (Agrt), VanR of Enterococcus faecium (Entfc), and Afq1 of Streptomyces coelicolor (Strco). Dashes indicate gaps
in amino acid sequence for optimal alignment. (B) RisS exhibited homology in the three functional regions to the histidine kinases EnvZ of E. coli, S. typhimurium,
and Salmonella typhi (Salti), CpxA of E. coli, PhoR of Shigella dysenteriae and E. coli, ResE of Bacillus subtilis, ArcB of E. coli, and DivJ of Caulobacter crescentus
(Caucr). The conserved functional residues are indicated by asterisks, identical residues are shaded, and the putative autophosphorylation site is indicated (Pi).
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1414 (C to G) and 1344 (conservative C-to-G exchange) (data
not shown). The overall sequence data (EMBL accession no.
Z97065, AJ224798, AJ224799, AJ224800, AJ224801, AJ224802,
AJ224803, and AJ224804) demonstrate that the ris locus is
highly conserved among different Bordetella spp.
Effect of the ris mutation on protein expression by B. bron-
chiseptica. Two-component systems are generally involved in
the coordinate regulation of several gene products (51, 53).
Therefore, their inactivation usually results in a highly pleio-
tropic effect. In an attempt to further characterize the role of
the Ris system in B. bronchiseptica physiology, whole-cell pro-
tein extracts from BB7866 and its ris derivative were analyzed
by two-dimensional gel electrophoresis. The comparative anal-
ysis showed that proteins with approximate molecular masses
of 80, 76, 68, 62, 53, 50, 39, 36, 30, and 16 kDa are downregu-
lated in the ris mutants, whereas others, of 95, 73, 58, 56, 42, 36,
26, and 20 kDa, seem to be repressed by ris (Fig. 5). This
suggests that the ris locus has a significant role in the regulation
of B. bronchiseptica gene expression.
Effect of ris mutation on the expression of bvg-independent
and bvg-repressed B. bronchiseptica products. Intracellular sur-
vival has been shown to be unaffected, or even favored, in
bvg-negative mutants (33, 34, 61, 63). This has led to the hy-
pothesis that bvg-independent or bvg-repressed gene products
play a role in intracellular survival. Therefore, the ris regula-
tory locus may be involved in the activation of bvg-independent
or bvg-repressed products. Urease production and motility are
characteristic phenotypes of B. bronchiseptica which are re-
pressed by bvg and, additionally, regulated by temperature (33,
34, 61, 63). Neither urease production nor motility was affected
in the ris mutants BB7865 ris and BB7866 ris (data not shown).
This suggests that the expression of the urease and motility
genes is ris independent.
We have previously identified an acid phosphatase that is
produced by B. bronchiseptica, but not by other Bordetella spp.
(13), which plays a role in bacterial intracellular survival. The
acid phosphatase activity was reduced by 85 and 87% in
BB7865 ris and by 49 and 75% in the BB7866 ris mutant when
cells were grown at 37 and 30°C in SS-X, respectively (Table 1).
FIG. 4. Regulation of ris expression. (A) The b-galactosidase activity of
B. bronchiseptica BB7865 risA9-9lacZ grown at 37°C in SS-X broth supplemented
with increasing NaCl concentrations, at 25°C in SS-X broth, at 37°C in SS-X
broth containing 5 mM nicotinic acid, at 37°C in SS-C broth containing 20 mM
MgSO4 or MgCl2, or at 37°C in SS-X broth at pH 5.8 was determined. BB7866
risA9-9lacZ was grown at 37°C in SS-X broth. The results are mean values of three
independent assays performed with independent strains harboring risA9-9lacZ
integrated at different sites. Standard errors of the mean are indicated by vertical
lines; differences with BB7865 risA9-9lacZ grown at 37°C in SS-X broth were
significant at P # 0.05 (M). (B) Determination of the b-galactosidase activity
produced by B. bronchiseptica BB7865 risA9-9lacZ recovered 4 and 24 h after
infection of CB1 cells. The results are means of data from three independent
assays; standard errors of the mean were less than 5%. Differences with the strain
BB7865 risA9-9lacZ grown in either Iscove’s or SS-X medium were significant at
P # 0.05 (M).
FIG. 5. Analysis of the protein expression patterns of B. bronchiseptica
BB7866 and BB7866 ris by two-dimensional gel electrophoresis. French press
lysates of BB7866 (A) and BB7866 ris (B) were separated by isoelectrofocusing
in the first dimension and by sodium dodecyl sulfate–10% polyacrylamide gel
electrophoresis in the second dimension; then proteins were identified by silver
staining. Protein spots detected in larger amounts in one strain are indicated by
open arrows, whereas those detected in only one strain are indicated by filled
arrows. The positions of molecular mass markers are indicated on the right.
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The phosphatase activity was restored in the ris mutants by
the chromosomal insertion of the ris locus (Table 1). These
complementation studies strongly suggest that acid phospha-
tase expression is regulated in response to environmental sig-
nals transduced by RisA-RisS.
Sensitivity to oxidative stress of B. bronchiseptica ris. One of
the strategies employed by intracellular pathogens to overcome
host oxygen-dependent clearance mechanisms (e.g., O2
z 2 and
H2O2) is the enzymatic conversion of oxidants by SOD (i.e.,
conversion of O2
z 2 to H2O2 and O2), catalase, or other oxid-
oreductases (i.e., conversion of H2O2 to H2O and O2). There-
fore, the sensitivity of B. bronchiseptica to killing by increased
levels of intracellular superoxide anion radicals generated by
the compound paraquat was analyzed (Table 2). The growth of
strain BB7865 was inhibited by paraquat when this organism
was cultured in SS-X medium, compared to its growth in bvg-
repressing SS-C medium and to the growth of strain BB7866 in
SS-X. Growth inhibition was increased in both BB7865 ris and
BB7866 ris, with respect to the growth of their parental strains,
under all growth conditions, and they generally exhibited a
higher sensitivity to paraquat on SS-X than on SS-C medium.
The complementation of the ris mutants by the chromosomal
integration of the ris locus restored resistance to reactive oxy-
gen. To expand these studies, the sensitivity of B. bronchisep-
tica to H2O2 was analyzed (Fig. 6). The viabilities of strains
BB7865, BB7866, and BB7865 ris were not significantly affect-
ed by a 30-min exposure to 1 mM H2O2. In contrast, after a
similar treatment, the number of viable cells of the mutant
strain BB7866 ris was reduced by 30%. When BB7865 and
BB7866 were exposed to 5 mM H2O2, reductions of viability
were observed after 15 min (25 and 46%, respectively). How-
ever, after 30 min, both strains regained viability with respect
to the control (100 and 70% of the inoculum, respectively). In
contrast, BB7865 ris and BB7866 ris exhibited steady reduc-
tions in viability after 30 min of exposure to H2O2 (40 and
64%, respectively).
These results suggest that ris and bvg are involved in the
expression of a product(s) which is required for bacterial re-
sistance to oxidative stress and is necessary for intracellular
survival. The initial, reversible reduction in the number of
viable bacteria observed after a 15-min exposure of the paren-
tal strains to H2O2 further supports the inducible nature of
these products. Interestingly, neither catalase nor SOD pro-
duction was affected in the ris mutants (data not shown). This
is in agreement with previous work (20, 29) which suggested
that neither sodA nor sodB is essential for intracellular survival
of Bordetella spp.
ris mutants exhibit an impaired capacity to persist in the
lungs of infected mice. The contribution of ris-regulated prod-
ucts to both bacterial resistance to oxidative stress and survival
in vitro within different cell lines prompted us to investigate the
capacity of ris mutants to infect and persist within the host.
Mice were infected by the intranasal route with either BB7865
or its ris derivative, and the numbers of viable bacteria present
in the lungs were determined at different time intervals (Fig.
7). While the number of microorganisms present in the lungs
of mice challenged with BB7865 increased progressively during
the first 4 days after infection, the clearance process of the ris
mutant started immediately (with an approximately 1.7-order-
FIG. 6. Sensitivity of B. bronchiseptica to H2O2. Bacteria were exposed to
1 mM (A) or 5 mM (B) H2O2, and the number of viable microorganisms was
determined. Results are expressed as the percentage of the initial inoculum and
are means of values from three independent experiments; standard errors of the
mean were less than 5%. Differences between the parental and the mutant strain
were significant at P # 0.05 (M).
TABLE 1. Determination of the acid phosphatase activity present
in French press lysates of B. bronchiseptica strains
Strain
Acid phosphatase activity when grown ona:
37°C 30°C
SS-X SS-C SS-X SS-C
BB7865 8.3 6 2.3 78.9 6 4.6 112.4 6 10.0 232.2 6 15.5
BB7865 ris 9.2 6 1.2 11.6 6 2.3 29.7 6 1.1 31.0 6 1.3
BB7865 ris::Tn5Tc-ris1 17.3 6 3.0 38.8 6 4.6 74.7 6 14.5 140.1 6 3.0
BB7866 67.0 6 6.0 67.5 6 2.5 80.6 6 5.2 181.5 6 9.3
BB7866 ris 26.7 6 4.2 34.5 6 0.4 38.5 6 1.9 45.2 6 1.0
BB7866 ris::Tn5Tc-ris1 55.6 6 1.8 57.1 6 7.1 110.78 6 7.8 165.15 6 20.1
a The reported results are means of values from three independent assays 6
standard errors of the mean and are expressed in milliunits of acid phosphatase
activity per milligram of protein.
TABLE 2. Susceptibility of B. bronchiseptica to paraquat
Strain
Growth inhibition zone on medium ata:
37°C 30°C
SS-X SS-C SS-X SS-C
BB7865 5 6 1 0 6 0 0 6 0 0 6 0
BB7865 ris 25 6 1 10 6 1 11 6 1 8 6 1
BB7865 ris::Tn5Tc-ris1 8 6 2 5 6 1 0 6 0 0 6 0
BB7866 0 6 0 0 6 0 0 6 0 0 6 0
BB7866 ris 11 6 0 11 6 1 8 6 0 6 6 1
BB7866 ris::Tn5Tc-ris1 0 6 0 0 6 0 0 6 0 0 6 0
a Growth inhibition is reported in millimeters measured in two axes relative to
the disk and averaged 6 the standard error of the mean.
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of-magnitude difference evident after 4 days). Then, the num-
ber of CFU recovered from the lungs of mice infected with the
parental strain slowly decreased, reaching a plateau at day 14
(approximately 4.5 log units). In contrast, the ris mutant was
rapidly eliminated, with the lungs being free of bacteria at day
14 postchallenge.
DISCUSSION
Bacterial survival in a particular niche requires a continuous
monitoring of external conditions and the ability to use this
information to develop an adaptive response. This response is
generally mediated by the up- and/or downregulation of ap-
propriate genes (24, 47). This requirement is very stringent for
pathogenic microorganisms whose transmission is not re-
stricted to host-to-host contact, since their infection cycles are
characterized by two phases, one within the host and another
consisting of bacterial release into the environment (24). In-
tracellular pathogens should further distinguish between the
extracellular and intracellular milieux, which are characterized
by different biochemical and physical parameters (e.g., nutrient
concentration, pH, osmolarity, etc.).
Many bacterial signal transduction pathways leading to ad-
aptation require two regulatory proteins, a sensor and a tran-
scriptional activator. The bvg locus of B. bronchiseptica encodes
one such system, which is responsible for regulating the ex-
pression of many virulence factors required during the infec-
tion cycle (52, 72). However, the observation that the intracel-
lular survival of B. bronchiseptica is bvg independent (33, 34,
61, 63) suggests that the expression of the required bacterial
products is either bvg independent or bvg repressed. We have
identified a novel two-component regulatory system (RisA-
RisS) which appears to be required for B. bronchiseptica’s re-
sistance to oxidative stress, production of a bvg-repressed acid
phosphatase, and in vivo persistence in mice. The ris locus ex-
hibits a high degree of homology to the E. coli ompR-envZ
genes, which are involved in osmoregulation (14), and to the
Salmonella typhimurium phoPQ genes, which are required for
the intraphagosomal activation of virulence genes (6, 49).
There are contrasting results regarding the in vivo modula-
tion of bvg and the overall contribution of bvg-repressed genes
to the infection process (1, 2, 8, 15, 16). Beattie et al. reported
that the inactivation of the bvg-repressed gene vrg-6 of B. per-
tussis results in an attenuation in mice and that B. bronchi-
septica constitutively expressing bvg colonizes the respiratory
tracts of guinea pigs less efficiently (8). In contrast, a recent
report suggests that neither the Bvg2 phase nor the vrg-6 locus
is required for infection of mice by B. pertussis (45). Further-
more, experiments performed in rabbits, using a Bvg1 phase-
locked mutant of B. bronchiseptica, showed that the Bvg1
phase is necessary and sufficient for infection and that bvg-
repressed genes are downregulated during colonization
(1, 2, 15). However, although antibodies against bvg-repressed
flagella were not observed after B. bronchiseptica infection of
rabbits (15), they were detected after infection of guinea pigs
(3). These last data indicate that bvg might be repressed in
certain niches within the host. The identification of a new class
of bvg-regulated products in B. bronchiseptica also suggests that
bvg-intermediate antigens might contribute to the bacterial
infection cycle, affecting host responses (16). This would reflect
a common feature of pathogenic bacteria, which after moving
into a new environment adjust protein synthesis to avoid the
extra energetic cost of synthesizing unnecessary products (24,
47). The PhoPQ system of S. typhimurium is inactive in extra-
FIG. 7. In vivo persistence of BB7865 and BB7865 ris in the lungs. BALB/c mice were infected intranasally with 106 bacteria each. Animals were sacrificed and lungs
were taken at 2 h and at 4, 8, 14, and 21 days after infection, and the numbers of viable bacteria per lung were determined. The results are averages of values for four
mice; standard errors of the mean are indicated by vertical lines. Differences between animals infected with the wild type and those infected with the mutant strain were
significant at P # 0.05 (M).
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cellular bacteria, allowing transcription of PhoP-repressed genes
that are required for entrance, and is active intracellularly,
leading to the transcription of PhoP-activated genes that are
important for intracellular survival (5, 6, 49).
The sequential appearance of antibodies against different
bvg-regulated virulence factors during infection (32), the se-
quential activation of virulence genes under permissive condi-
tions (62), and the temperature-dependent regulation of some
bvg-repressed genes (46, 74) suggest that bvg is part of a reg-
ulatory network in which additional factors are required to
fine-tune gene expression during the course of infection. Thus,
it is likely that both bvg and additional regulators such as ris
interact, influencing the expression of proteins required in the
intracellular survival process. Interactions between two-com-
ponent systems are widely distributed; e.g., in the Pho regulon
of Bacillus subtilis, three such systems interact to coordinate
the expression of phoPR (68). The results presented here show
that ris activation is independent of bvg but that both regula-
tory systems act antagonistically on the expression of putative
survival-relevant products. Temperature and ion (e.g., Mg21 and
SO4
2) concentrations may allow B. bronchiseptica to distinguish
between the external environment and specific niches within the
host. A temperature of 37°C favors ris expression; additionally, in
vivo expression of ris is modulated by the Mg21 concentration,
similarly to intracellularly expressed Salmonella genes (26, 27).
The physiopathogenesis of B. bronchiseptica survival within
eukaryotic cells has yet to be completely elucidated. The work
reported here demonstrates that the ris locus is conserved
among all Bordetella spp. However, only B. bronchiseptica can
survive within dendritic cells (33, 34), and in contrast to B. per-
tussis, survival is bvg independent (22, 23, 25, 60). Interestingly,
recent studies by Banemann and Gross (7) provide evidence
that bvg-negative strains may have a selective advantage to
survive intracellularly in macrophages. Paraquat generates in-
tracellular O2
z 2, which by further reduction and autooxidation
can accumulate as toxic hydroxyl radicals, whereas H2O2 is an
important component of the respiratory burst and can react
with iron or copper ions to also generate hydroxyl radicals (12).
The ris mutants are more susceptible to both compounds, sug-
gesting that ris regulates a protein(s) required to survive accu-
mulation of hydroxyl radicals, O2
z 2, and H2O2. Catalase and
SOD production are not affected in the ris mutants (data not
shown). This suggests that ris may also regulate the expression
of an unknown oxidoreductase which mediates resistance
against intracellular killing mechanisms.
Acid phosphatases have been recognized as virulence factors
able to improve the intracellular survival capacities of several
microorganisms (21, 56). The acid phosphatase produced by
B. bronchiseptica also appears to be involved in the intracellu-
lar survival process (13). The ris-dependent expression of acid
phosphatase further supports a role for the ris locus in the regu-
lation of virulence-associated rather than metabolic genes. Acid
phosphatase and resistance to paraquat were shown to be re-
pressed by bvg and to be dependent on ris activation. Whether
acid phosphatase is directly involved in the resistance to O2
z 2,
or phosphatase production and resistance to O2
z 2 are depen-
dent on the same regulatory system, remains to be elucidated.
Interestingly, the expression of the ris locus was upregulated
when bacteria were infecting eukaryotic cells (Fig. 4B), suggest-
ing a role for ris-regulated products in this stage of the infec-
tion process. This hypothesis was further supported by the rap-
id clearance of the ris mutant observed in mouse colonization
studies. These results indicate that ris-regulated products are
required for persistent infection and resistance to the non-
specific clearance mechanisms of the innate immune response.
Therefore, ris-regulated products may contribute to the persis-
tence and chronic progression of B. bronchiseptica infections. The
identification of other ris-dependent products would allow elu-
cidation of the interplay between bvg-dependent and ris-de-
pendent products and would contribute to the overall under-
standing of the strategies employed by B. bronchiseptica to
survive in vivo.
ACKNOWLEDGMENTS
We gratefully acknowledge E. Medina for stimulating discussions
and critical reading of the manuscript, A. Mu¨ller for outstanding tech-
nical assistance, and K. N. Timmis for generous support and encour-
agement.
This work was partially supported by grants from the Lower Saxony-
Israel Cooperation Programme, founded by the Volkswagen Founda-
tion (21.45-75/2), the DAAD Acciones Integradas Hispano-Alemanas
Programme (314-AI-e-dr), and the Australian National Health and
Medical Research council (930123). N.P.W. is the recipient of a Uni-
versity of Wollongong postgraduate research award.
REFERENCES
1. Akerley, B. J., P. A. Cotter, and J. F. Miller. 1995. Ectopic expression of the
flagellar regulon alters development of the Bordetella-host interaction. Cell
80:611–620.
2. Akerley, B. J., and J. F. Miller. 1996. Understanding signal transduction
during bacterial infection. Trends Microbiol. 4:141–146.
3. Akerley, B. J., D. M. Monack, S. Falkow, and J. F. Miller. 1992. The bvgAS
locus negatively controls motility and synthesis of flagella in Bordetella bron-
chiseptica. J. Bacteriol. 174:980–990.
4. Alexeyev, M. F., I. N. Shokolenko, and T. P. Croughan. 1995. New mini-Tn5
derivatives for insertion mutagenesis and genetic engineering in gram-neg-
ative bacteria. Can. J. Microbiol. 41:1053–1055.
5. Alpuche Aranda, C. M., E. L. Racoosin, J. A. Swanson, and S. I. Miller. 1994.
Salmonella stimulate macrophage macropinocytosis and persist within spa-
cious phagosomes. J. Exp. Med. 179:601–608.
6. Alpuche Aranda, C. M., J. A. Swanson, W. P. Loomis, and S. I. Miller. 1992.
Salmonella typhimurium activates virulence gene transcription within acidi-
fied macrophage phagosomes. Proc. Natl. Acad. Sci. USA 89:10079–10083.
7. Banemann, A., and R. Gross. 1997. Phase variation affects long-term survival
of Bordetella bronchiseptica in professional phagocytes. Infect. Immun. 65:
3469–3473.
8. Beattie, D. T., R. Shahin, and J. J. Mekalanos. 1992. A vir-repressed gene of
Bordetella pertussis is required for virulence. Infect. Immun. 60:571–577.
9. Bromberg, K., G. Tannis, and P. Steiner. 1991. Detection of Bordetella
pertussis associated with the alveolar macrophages of children with human
immunodeficiency virus infection. Infect. Immun. 59:4715–4719.
10. Brosius, J. 1984. Plasmid vectors for the selection of promoters. Gene 27:
151–160.
11. Buchmeier, N., S. Bossie, C.-Y. Chen, F. C. Fang, D. G. Guiney, and S. J.
Libby. 1997. SlyA, a transcriptional regulator of Salmonella typhimurium, is
required for resistance to oxidative stress and is expressed in the intracellular
environment of macrophages. Infect. Immun. 65:3725–3730.
12. Buchmeier, N. A., and F. Heffron. 1989. Intracellular survival of wild-type
Salmonella typhimurium and macrophage-sensitive mutants in diverse pop-
ulations of macrophages. Infect. Immun. 57:1–7.
13. Chhatwal, G. S., M. J. Walker, H. Yan, K. N. Timmis, and C. A. Guzman.
1997. Temperature dependent expression of an acid phosphatase by Borde-
tella bronchiseptica: role in intracellular survival. Microb. Pathog. 22:257–264.
14. Comeau, D. E., K. Ikenaka, K. Tsung, and M. Inouye. 1985. Primary char-
acterization of the protein products of the Escherichia coli ompB locus:
structure and regulation of synthesis of the OmpR and EnvZ proteins. J.
Bacteriol. 164:578–584.
15. Cotter, P. A., and J. F. Miller. 1994. BvgAS-mediated signal transduction:
analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a
rabbit model. Infect. Immun. 62:3381–3390.
16. Cotter, P. A., and J. F. Miller. 1997. A mutation in the Bordetella bronchi-
septica bvgS gene results in reduced virulence and increased resistance to
starvation, and identifies a new class of Bvg-regulated antigens. Mol. Micro-
biol. 24:671–685.
17. Dassa, E., M. Cahu, B. Desjoyaux-Cherel, and P. L. Boquet. 1982. The acid
phosphatase with optimum pH of 2.5 of Escherichia coli: physiological and
biochemical study. J. Biol. Chem. 257:6669–6676.
18. de Lorenzo, V., M. Herrero, U. Jakubzik, and K. N. Timmis. 1990. Mini-Tn5
transposon derivatives for insertion mutagenesis, promoter probing, and
chromosomal insertion of cloned DNA in gram-negative eubacteria. J. Bac-
teriol. 172:6568–6572.
19. DeShazer, D., J. D. Bannan, M. J. Moran, and R. L. Friedman. 1994.
Characterization of the gene encoding superoxide dismutase of Bordetella
pertussis and construction of a SOD-deficient mutant. Gene 142:85–89.
VOL. 66, 1998 NOVEL TWO-COMPONENT SYSTEM OF B. BRONCHISEPTICA 4649
 o
n
 O
ctober 12, 2015 by University of Queensland Library
http://iai.asm
.org/
D
ow
nloaded from
 
20. DeShazer, D., G. E. Wood, and R. L. Friedman. 1994. Molecular character-
ization of catalase from Bordetella pertussis: identification of the katA pro-
moter in an upstream insertion sequence. Mol. Microbiol. 14:123–130.
21. Dowling, J. N., A. K. Saha, and R. H. Glew. 1992. Virulence factors of the
family Legionellaceae. Microbiol. Rev. 56:32–60.
22. Ewanowich, C. A., A. R. Melton, A. A. Weiss, R. K. Sherburne, and M. S.
Peppler. 1989. Invasion of HeLa 229 cells by virulent Bordetella pertussis.
Infect. Immun. 57:2698–2704.
23. Ewanowich, C. A., R. K. Sherburne, S. F. P. Man, and M. S. Peppler. 1989.
Bordetella parapertussis invasion of HeLa 229 cells and human respiratory
epithelial cells in primary culture. Infect. Immun. 57:1240–1247.
24. Finlay, B. B., and S. Falkow. 1989. Common themes in microbial pathoge-
nicity. Microbiol. Rev. 53:210–230.
25. Friedman, R. L., K. Nordensson, L. Wilson, E. T. Akporiaye, and D. E. Yo-
cum. 1992. Uptake and intracellular survival of Bordetella pertussis in human
macrophages. Infect. Immun. 60:4578–4585.
26. Garcia del Portillo, F., J. W. Foster, M. E. Maguire, and B. B. Finlay. 1992.
Characterization of the micro-environment of Salmonella typhimurium-con-
taining vacuoles within MDCK epithelial cells. Mol. Microbiol. 6:3289–3297.
27. Garcia Vescovi, E., F. C. Soncini, and E. A. Groisman. 1996. Mg21 as an
extracellular signal: environmental regulation of Salmonella virulence. Cell
84:165–174.
28. Goodnow, R. A. 1980. Biology of Bordetella bronchiseptica. Microbiol. Rev.
44:722–738.
29. Graeff-Wohlleben, H., S. Killat, A. Banemann, N. Guiso, and R. Gross. 1997.
Cloning and characterization of an Mn-containing superoxide dismutase
(SodA) of Bordetella pertussis. J. Bacteriol. 179:2194–2201.
30. Gray, D. F., and C. Cheers. 1967. The steady state in cellular immunity. II. Im-
munological complaisance in murine pertussis. J. Exp. Biol. Med. Sci. 45:417–426.
31. Gross, R., and R. Rappuoli. 1989. Pertussis toxin promoter sequences in-
volved in modulation. J. Bacteriol. 171:4026–4030.
32. Gueirard, P., and N. Guiso. 1993. Virulence of Bordetella bronchiseptica: role
of adenylate cyclase-hemolysin. Infect. Immun. 61:4072–4078.
33. Guzman, C. A., M. Rohde, M. Bock, and K. N. Timmis. 1994. Invasion and
intracellular survival of Bordetella bronchiseptica in mouse dendritic cells.
Infect. Immun. 62:5528–5537.
34. Guzman, C. A., M. Rohde, and K. N. Timmis. 1994. Mechanisms involved in
uptake of Bordetella bronchiseptica by mouse dendritic cells. Infect. Immun.
62:5538–5544.
35. Hanada, M., K. Shimoda, Y. Nakase, and Y. Nishiyama. 1979. Production of
lesions similar to naturally occurring swine atrophic rhinitis by cell-free
sonicated extract of Bordetella bronchiseptica. Jpn. J. Vet. Sci. 41:1–8.
36. Herrero, M., V. de Lorenzo, and K. N. Timmis. 1990. Transposon vectors
containing non-antibiotic resistance selection markers for cloning and stable
chromosomal insertion of foreign genes in gram-negative bacteria. J. Bacte-
riol. 172:6557–6567.
37. Hewlett, E. L., M. A. Urban, C. R. Manclark, and J. Wolff. 1976. Extracy-
toplasmic adenylate cyclase of Bordetella pertussis. Proc. Natl. Acad. Sci.
USA 73:1926–1930.
38. Hoch, J. A., and T. J. Silhavy. 1995. Two-component signal transduction.
ASM Press, Washington, D.C.
39. Horiguchi, Y., H. Matsuda, H. Koyama, T. Nakai, and K. Kume. 1992.
Bordetella bronchiseptica dermonecrotizing toxin suppresses in vivo antibody
responses in mice. FEMS Microbiol. Lett. 69:229–234.
40. Kornfeld, S., and I. Mellman. 1989. The biogenesis of lysosomes. Annu. Rev.
Cell Biol. 5:483–525.
41. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of
the head of bacteriophage T4. Nature 227:680–685.
42. Leininger, E., C. A. Ewanowich, A. Bhargava, M. S. Peppler, J. G. Kenimer,
and M. J. Brennan. 1992. Comparative roles of the Arg-Gly-Asp sequence
present in the Bordetella pertussis adhesins pertactin and filamentous hem-
agglutinin. Infect. Immun. 60:2380–2385.
43. Li, J., N. F. Fairweather, P. Novotny, G. Dougan, and I. G. Charles. 1992.
Cloning, nucleotide sequence and heterologous expression of the protective
outer-membrane protein P.68 pertactin from Bordetella bronchiseptica.
J. Gen. Microbiol. 138:1697–1705.
44. Liljestrom, P., I. Laamanen, and E. T. Palva. 1988. Structure and expression
of the ompB operon, the regulatory locus for the outer membrane porin
regulon in Salmonella typhimurium LT-2. J. Mol. Biol. 201:663–673.
45. Martinez de Tejada, G., P. A. Cotter, U. Heininger, A. Camilli, B. J. Akerley,
J. J. Mekalanos, and J. F. Miller. 1998. Neither the Bvg2 phase nor the vrg6
locus of Bordetella pertussis is required for respiratory infection of mice.
Infect. Immun. 66:2762–2768.
46. McMillan, D. J., M. Shojaei, G. S. Chhatwal, C. A. Guzman, and M. J.
Walker. 1996. Molecular analysis of the bvg-repressed urease of Bordetella
bronchiseptica. Microb. Pathog. 21:379–394.
47. Mekalanos, J. J. 1992. Environmental signals controlling expression of vir-
ulence determinants in bacteria. J. Bacteriol. 174:1–7.
48. Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, N.Y.
49. Miller, S. I., A. M. Kukral, and J. J. Mekalanos. 1989. A two-component
regulatory system (phoP phoQ) controls Salmonella typhimurium virulence.
Proc. Natl. Acad. Sci. USA 86:5054–5058.
50. Miller, V. L., and J. J. Mekalanos. 1988. A novel suicide vector and its use
in construction of insertion mutations: osmoregulation of outer membrane
proteins and virulence determinants in Vibrio cholerae requires toxR. J.
Bacteriol. 170:2575–2583.
51. Mizuno, T., and S. Mizushima. 1990. Signal transduction and gene regulation
through the phosphorylation of two regulatory components: the molecular basis
for the osmotic regulation of the porin genes. Mol. Microbiol. 4:1077–1082.
52. Monack, D. M., B. Arico, R. Rappuoli, and S. Falkow. 1989. Phase variants
of Bordetella bronchiseptica arise by spontaneous deletions in the vir locus.
Mol. Microbiol. 3:1719–1728.
53. Msadek, T., F. Kunst, and G. Rapoport. 1993. Two-component regulatory
systems, p. 729–745. In A. L. Sonenshein, J. A. Hoch, and R. Losick (ed.),
Bacillus subtilis and other gram-positive bacteria: biochemistry, physiology,
and molecular genetics. American Society for Microbiology, Washington, D.C.
54. Paglia, P., G. Girolomoni, F. Robbiati, F. Granucci, and P. Ricciardi Castag-
noli. 1993. Immortalized dendritic cell line fully competent in antigen pre-
sentation initiates primary T cell responses in vivo. J. Exp. Med. 178:1893–1901.
55. Pearson, W. R. 1990. Rapid and sensitive sequence comparison with FASTP
and FASTA. Methods Enzymol. 183:63–98.
56. Remaley, A. T., D. B. Kuhns, R. E. Basford, R. H. Glew, and S. S. Kaplan.
1984. Leishmanial phosphatase blocks neutrophil O22 production. J. Biol.
Chem. 259:11173–11175.
57. Roop, R. M., II, H. P. Veit, R. J. Sinsky, S. P. Veit, E. L. Hewlett, and E. T.
Kornegay. 1987. Virulence factors of Bordetella bronchiseptica associated
with the production of infectious atrophic rhinitis and pneumonia in exper-
imentally infected neonatal swine. Infect. Immun. 55:217–222.
58. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a
laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold
Spring Harbor, N.Y.
59. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with
chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463–5467.
60. Saukkonen, K., C. Cabellos, M. Burroughs, S. Prasad, and E. Tuomanen.
1991. Integrin-mediated localization of Bordetella pertussis within macro-
phages: role in pulmonary colonization. J. Exp. Med. 173:1143–1149.
61. Savelkoul, P. H., B. Kremer, J. G. Kusters, B. A. van der Zeijst, and W.
Gaastra. 1993. Invasion of HeLa cells by Bordetella bronchiseptica. Microb.
Pathog. 14:161–168.
62. Scarlato, V., B. Arico, A. Prugnola, and R. Rappuoli. 1991. Sequential acti-
vation and environmental regulation of virulence genes in Bordetella pertus-
sis. EMBO J. 10:3971–3975.
63. Schipper, H., G. F. Krohne, and R. Gross. 1994. Epithelial cell invasion and
survival of Bordetella bronchiseptica. Infect. Immun. 62:3008–3011.
64. Smith, A. M., and M. J. Walker. 1996. Transfer of a pertussis toxin expres-
sion locus to isogenic bvg-positive and bvg-negative Bordetella bronchiseptica
using an in vivo technique. Microb. Pathog. 20:263–273.
65. tainer, D. W., and M. J. Scholte. 1970. A simple chemically defined medium for
the production of phase I Bordetella pertussis. J. Gen. Microbiol. 63:211–220.
66. Steed, L. L., M. Setareh, and R. L. Friedman. 1991. Intracellular survival of
virulent Bordetella pertussis in human polymorphonuclear leukocytes. J. Leu-
koc. Biol. 50:321–330.
67. Stock, J. B., A. J. Ninfa, and A. M. Stock. 1989. Protein phosphorylation and
regulation of adaptive responses in bacteria. Microbiol. Rev. 53:450–490.
68. Sun, G., S. M. Birkey, and F. M. Hulett. 1996. Three two-component signal-
transduction systems interact for Pho regulation in Bacillus subtilis. Mol.
Microbiol. 19:941–948.
69. Switzer, W. P., and D. O. Farrington. 1981. Bordetellosis, p. 497–507. In
A. D. Leman, R. D. Glock, W. L. Mengeling, R. H. C. Penny, E. Scholl, and
B. Straw (ed.), Diseases in swine. Iowa State University Press, Ames.
70. von Hippel, P. H., D. G. Bear, W. D. Morgan, and J. A. McSwiggen. 1984.
Protein-nucleic acid interactions in transcription: a molecular analysis.
Annu. Rev. Biochem. 53:389–446.
71. Walker, M. J., C. A. Guzma´n, M. Rohde, and K. N. Timmis. 1991. Produc-
tion of recombinant Bordetella pertussis serotype 2 fimbriae in Bordetella
parapertussis and Bordetella bronchiseptica: utility of Escherichia coli gene
expression signals. Infect. Immun. 59:1739–1746.
72. Weiss, A. A., and S. Falkow. 1984. Genetic analysis of phase change in
Bordetella pertussis. Infect. Immun. 43:263–269.
73. Weiss, A. A., E. L. Hewlett, G. A. Myers, and S. Falkow. 1983. Tn5-induced mu-
tations affecting virulence factors of Bordetella pertussis. Infect. Immun. 42:33–41.
74. West, N. P., J. T. Fitter, U. Jakubzik, M. Rohde, C. A. Guzman, and M. J.
Walker. 1997. Non-motile mini-transposon mutants of Bordetella bronchisep-
tica exhibit altered abilities to invade and survive in eukaryotic cells. FEMS
Microbiol. Lett. 146:263–269.
Editor: J. R. McGhee
4650 JUNGNITZ ET AL. INFECT. IMMUN.
 o
n
 O
ctober 12, 2015 by University of Queensland Library
http://iai.asm
.org/
D
ow
nloaded from
 
